L. Vavrušová

680 total citations
7 papers, 100 citations indexed

About

L. Vavrušová is a scholar working on Clinical Psychology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, L. Vavrušová has authored 7 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Clinical Psychology, 3 papers in Psychiatry and Mental health and 2 papers in Experimental and Cognitive Psychology. Recurrent topics in L. Vavrušová's work include Schizophrenia research and treatment (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Mental Health Research Topics (2 papers). L. Vavrušová is often cited by papers focused on Schizophrenia research and treatment (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Mental Health Research Topics (2 papers). L. Vavrušová collaborates with scholars based in Poland, Slovakia and Hungary. L. Vavrušová's co-authors include Marek Jarema, Dan J. Stein, Valérie Olivier, Antti Ahokas, F. Picarel-Blanchot, Christian de Bodinat, István Bitter, Cyril Höschl, А С Аведисова and Олег Чабан and has published in prestigious journals such as European Neuropsychopharmacology, European Psychiatry and PubMed.

In The Last Decade

L. Vavrušová

7 papers receiving 95 citations

Peers

Countries citing papers authored by L. Vavrušová

Since Specialization

Citations

This map shows the geographic impact of L. Vavrušová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Vavrušová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Vavrušová more than expected).

Fields of papers citing papers by L. Vavrušová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Vavrušová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Vavrušová. The network helps show where L. Vavrušová may publish in the future.

Co-authorship network of co-authors of L. Vavrušová

This figure shows the co-authorship network connecting the top 25 collaborators of L. Vavrušová. A scholar is included among the top collaborators of L. Vavrušová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Vavrušová. L. Vavrušová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder 2018 ·European Neuropsychopharmacology ·Dan J. Stein, Jon‐Paul Khoo, Antti Ahokas, Marek Jarema, Michael Van Ameringen, L. Vavrušová, Cyril Höschl, Michael Bauer, István Bitter, Sergey Mosolov, Valérie Olivier, (unknown), F. Picarel-Blanchot, Christian de Bodinat	23
2	Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study 2017 ·European Neuropsychopharmacology ·Dan J. Stein, Antti Ahokas, Marek Jarema, А С Аведисова, L. Vavrušová, Олег Чабан, (unknown), Valérie Olivier, F. Picarel-Blanchot, Christian de Bodinat	32
3	Schizophrenia causes significant burden to patients' and caregivers' lives. 2016 ·PubMed ·(unknown), (unknown), (unknown), Miro Jakovljević, Vlado Jukić, Kaire Aadamsoo, Sven Janno, István Bitter, (unknown), Marek Jarema, Slobodan Јаnkovic, Ján Pečeňák, L. Vavrušová, Rok Tavčar, (unknown), Darren A. Talbot, (unknown)	24
4	Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries. 2016 ·PubMed ·(unknown), (unknown), (unknown), Miro Jakovljević, Vlado Jukić, Kaire Aadamsoo, Sven Janno, István Bitter, (unknown), Marek Jarema, Slobodan Јаnkovic, Ján Pečeňák, L. Vavrušová, Rok Tavčar, (unknown), Darren A. Talbot, (unknown)	8
5	What Are the Characteristics of Patients Compliant with Antipsychotic Medication? 2015 ·European Psychiatry ·L. Vavrušová	1
6	P.2.a.024 Quetiapine XR monotherapy and quetiapine XR+ongoing antidepressant versus lithium+ongoing AD for Stage II treatment-resistant major depressive disorder 2010 ·European Neuropsychopharmacology ·(unknown), Maria Luísa Figueira, Petar Petrov, (unknown), L. Vavrušová, (unknown), L. Jörgensen, Jürgen Köhler, Michael Bauer	2
7	The impact of migration on mental health and mental illness 2008 ·European Psychiatry ·Cyril Höschl, Pedro Ruiz, Miguel Casas, M. Musalek, Wolfgang Gäebel, L. Vavrušová	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact